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A B S T R A C T
Introduction: Malignant musculoskeletal tumors in children are mostly comprised of Osteosarcoma and Ewing's
sarcoma and distal femur is the most common site for primary bone tumors. This study examined the surgical
management outcomes of pediatric patients (< 18 years) presented in our setup with malignant distal femur
tumors.
Methodology: We retrospectively reviewed the medical records of patients diagnosed with malignant sarcomas of
distal femur and younger than 18 years of age who underwent limb salvage surgery during June
2009–June2017.
Results: There were 31 pediatric patients who had distal femur malignant tumors and out of them 20 patients
were selected who underwent limb salvage as a primary surgery. The mean age (range) of patients was 11.90
(6–17) years. Seventeen had osteosarcoma and three had Ewing's sarcoma. In surgery all patients were offered
reconstruction. Post-operative complications were observed in (50%) patients while other 50% patients had no
complications. Wound infection, flap necrosis, broken plates with non-union and recurrence of disease were the
reported complications. Revision surgery was performed in 10 patients out of 20 patients.
Conclusion: Salvage was the primary option in our surgery and revision surgery was performed in the cases due
to complications. Small sample size was the limitation of the study.
1. Introduction
Malignant bone tumors are disease of the young bone. Pediatric
patients suffer the maximum burden of primary bone tumors [1]. It's a
great challenge for the surgeon, oncologist and physiotherapist to deal
in management of this age group. Furthermore, the psychosocial impact
on the child and the parents can't be ignored. Fortunately, in the last 3
decades there was dramatic increase in the 5 year survival rates of these
tumors, from 10% to over 70%, thanks to the combination of new
chemotherapeutic agents, advanced reconstruction techniques and the
affordable, effective and durable alternates at resource constrained
country like ours [2]. This survival is long enough to justify the complex
procedures in limb sparing surgery. At this era, limb-salvage procedures
are the gold standard for most of the cases [3]. Amputation is re-
commended in very selective patients and cases.
Malignant musculoskeletal tumors in children are mostly comprised
of Osteosarcoma and Ewing's sarcoma. Among all malignancies ex-
cluding leukemia and lymphoma, Osteosarcoma comprises of 3–5%
cases of malignant tumors in children [4]. The distal femur is the most
common site involved [5]. Not only is this an anatomically critical site
involving a significant joint, but also, being in lower limb, hinders the
weight bearing and functional status of the child. Managing such tu-
mors require a highly professional team compromising of an orthopedic
tumor surgeon, oncologist, pediatrician, radiotherapist, physiotherapist
and nurses [6]. Growing skeleton of the child adds to the challenge. You
won't be able to use fixed, rigid prosthesis as used in adults. Dynamic
growing prostheses are too expensive for our patients who pay their
health care services out of their pockets [7]. At our side of the world,
multiple cost-effective alternates have been in use [8]. These include
parental fibula, vascularized autografts and autoclaved tumor bone.
Vascularized free fibula grafting was introduced in 1970 for re-
construction in bone tumors and it was shown to have benefits to pa-
tients receiving radio/chemotherapy. This type of free fibula grafting
also remains viable in infections. Although they possess the ability to
unite and remodel with the host bone and increase in strength, free
fibulas initially lack the structural support of large cortical allografts
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[9].The present study is conducted to share our experience of man-
agement of malignant distal femur tumor in children and show the low
cost innovations with affordable care.
2. Methodology
A retrospective cross sectional study was planned and the medical
record files of all the patients diagnosed with malignant sarcomas of
distal femur and younger than 18 years of age, who underwent limb
salvage surgery in Aga University hospital during June 2009–June2017
were reviewed. It was a single centered study. Adult Patients (>=18
years) that were diagnosed with any benign bone tumors and other than
distal femur site with malignant tumor diagnosis were excluded from
the study. Study protocol was submitted in ERC and was granted ex-
emption from hospitals Ethics review committee as it was a retro-
spective audit.
Data was extracted from patient's medical record file and entered on
statistical software SPSS 21. A structured proforma was used for data
collection. The data was collected for the following variables; demo-
graphics including: age, gender. Moreover, information was also taken
on tumor site, surgery details, reconstruction, and histopathology,
complications, neo-adjuvant and adjuvant therapy. Since it was retro-
spective audit so the patients last follow up was recorded only and no
further follow up was done. All the descriptive analysis of data was
done and results were reported as frequencies and mean. This study has
been registered in research registry, number is researchregistry4695
and it is being reported in line with STROCSS research reporting
guidelines [10].
3. Results
There were 31 pediatric patients who had distal femur malignant
tumors and out of them 20 patients were selected who underwent limb
salvage as a primary surgery. The mean age (range) of patients was
11.90 years (Table 1). There were 11 females (55.0%) and 9 males
(45%). Seventeen patients (85.5%), had osteosarcoma and three (15%)
had Ewing's sarcoma. Patients were treated with surgery, neo-adjuvant
and adjuvant chemotherapy. All patients had neo-adjuvant and ad-
juvant chemo therapy which was given according to EURAMOS and
COG protocol, while only 1 patient underwent adjuvant radiotherapy.
In surgery all patients were offered reconstruction.
The reconstruction method used were: vascular fibula with platting
(single, double fibula), mega prosthesis insertion, patients, autoclave
bone and allograft from parental fibula (Table 2). 12 patients had right
distal femur disease (60.0%) and 8(40.0%) had left side affected.
Post-operative complications were observed in 10 (50%) patients
while other 10 patients had no complications. Wound infection oc-
curred in 3 patients, 1 patients had flap necrosis, and 5 had broken
plates with non-union, while 1 had recurrence of disease (Fig. 1). Re-
vision surgery was performed in 10 patients out of 20 patients. Am-
putation as a revision surgery option as a result of complications was
done in 4 (20%) patients while 16 (80%) had other revision surgeries
comprising of removal of broken implant, bone grafting with BMP
(bone morphogenic protein) and wound debridement.
Post-operative complications were observed in 10 (50%) patients
while other 10 patients had no complications. Wound infection oc-
curred in 3 patients, 1 patients had flap necrosis, and 5 had broken
plates with non-union, while 1 had recurrence of disease (Fig. 1). Re-
vision surgery was performed in 10 patients out of 20 patients.
Amputation as a revision surgery option as a result of complications
was done in 4 (20%) patients while 16 (80%) had other revision sur-
geries comprising of removal of broken implant, bone grafting with
BMP (bone morphogenic protein) and wound debridement.
4. Discussion
Bone and soft tissue sarcomas are rare mesenchymal malignancies
that arise in 2–4 per 100,000 head of population [11]. Most common
being Osteosarcoma and Ewing sarcoma. Affecting the distal femur
most commonly. Worldwide there is a dramatic increase in 5-year
survival rate in the last 3 decades after introducing newer chemother-
apeutic agents, advances in imaging modalities and advanced training
and surgical techniques in orthopedic tumor cases [11]. Even patients
with advanced stage and those with metastases at time of diagnosis
have better outcomes due to these chemotherapeutic agents and sur-
gical excision of the primary tumor along with the metastases [12].
Surgery to resect the tumor followed by reconstructions to preserve
function, mobility, and esthetics (limb-sparing surgery) has now re-
placed amputation as the primary form of surgical intervention
[13–15]. All of our patients in current study offered reconstruction after
wide margin excision. All had neo-adjuvant chemotherapy based on
EURAMOS and COG protocols, while only 1 patient had adjuvant
radiotherapy. Only 2 patients had the opportunity to have mega pros-
thesis. The maximum number of patients 13 had biologic reconstruction
using vascularized fibular graft fixed with locking plate. Innovative
techniques, based on the resource-constrained circumstances we have,
were utilized in the remaining patients. Like allograft from parental
fibula and autografts from autoclaved bone.
Complications such as periprosthetic fracture, breakage of plate,
prominent implant, non-union at host-graft junction and bone and joint
stiffness have all been reported in literature. In our series, we have
encountered complications in 10 patients. Wound infection, flap ne-
crosis, broken plates with non-union and recurrence of disease were
also found in our patients. Revision surgery was performed in half of
the patients. Amputation as a revision surgery option as a result of
complications was done in 4 patients while 16 had other revision sur-
geries comprising of removal of broken implant, bone grafting with
BMP (bone morphogenic protein), and wound debridement and dis-
traction osteogenesis by ilizarov apparatus.
Not only we have scarcity of relevant published literature and
health care rules and regulations which are near to minimum, but also
the inadequate awareness and limited diagnostic and therapeutic spe-
cialized facilities make it real challenging to manage such tumors at our
setup.
Definite diagnosis is mandatory before any attempt at surgical in-
tervention. In reality, this sometimes is difficult and patients with
malignant bone disease can be misdiagnosed as having benign lesions.
This is a rare disease you won't encounter much in your practice as a
general orthopedic surgeon so it's always helpful to follow international
guidelines like the National Comprehensive Cancer Network (NCCN).
They recommend referring all patients younger than 40 years of age
who present to you with bone pain, and a suspicious lesion on x-ray, to
an orthopedic oncologist for biopsy and further management.
Table 1
Age descriptives of patients (Years).
n Minimum Maximum Mean Std. Deviation
20 6 17 11.90 3.227
Table 2
Methods of reconstruction.
Type of reconstruction Frequency %
Vascular fibula with platting 13 65.0
Mega prosthesis 2 10.0
Autoclave bone 4 20.0
Allograft 1 5.0
Total 20 100.0
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5. Conclusion
The increase in awareness of the patients and the surgeons towards
this highly sophisticated subspecialty will make early referral to spe-
cialized centers easier task, hence the better long term outcome for
these children. The limitations of this study was a retrospective data
collection which didn't allow us to find the present survival status of
patients. We emphasize that the experts who received advanced
training in Orthopedics tumor surgery should deal such cases.
Orthopedics societies should guide surgeons to refer such cases to the
concerned to save the lives and limbs of our patients. Multiple options
of reconstructions are available. In resource-constrained settings, there
are affordable, durable and effective options of reconstructions as well.
The multidisciplinary approach and team work yield the best results to
spare the limb of these children and grant them a better quality life.
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